Merck KGaA cut its mid-term sales growth target for its health-care division after a number of high-profile drug trial ...

Fintel reports that on October 16, 2024, Raymond James upgraded their outlook for Wave Life Sciences (NasdaqGM:WVE) from ...

Private equity investors including Quadria Capital and TPG Capital have expressed initial interest to invest about $100 ...

Kezar Life Sciences announced the termination of Phase 2b PALIZADE clinical trial of zetomipzomib, an investigational therapy ...

Kezar Life Sciences has become the latest biotech to decide that it could do better than a buyout offer from Concentra ...

Earlier this month, Kezar Life Sciences announced that the mid-stage test of zetomipzomib in lupus nephritis had been placed ...

Kezar (KZR) is discontinuing development of its drug zetomipzomib for the treatment of lupus nephritis so it can focus on ...

NASA announced two awards Thursday to establish scientific consortia – multi-institutional coalitions to conduct ground-based studies that help address the agency’s goals of maintaining a sustained ...

In recent trading, 180 Life Sciences Corp (ATNF) stock price has shown some volatility, fluctuating 372.26% over the last five trades and 225.13% over the past 30 trades. This represents a notable ...

The interim dean of the University of Wyoming’s College of Agriculture, Life Sciences and Natural Resources has been named ...

How did early cells keep themselves distinct while allowing for some amount of exchange?

The analysis named the 25 U.S. life science startups most likely to go public, including a Denver-based diabetes treatment ...